Opaleye Management
$1.1B 13F equity value
66 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Opaleye Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 2,447,500 | $195M | 17.7% |
| ETON | ETON PHARMACEUTICALS INC | 2,860,000 | $104M | 9.4% |
| HROW | HARROW INC | 2,400,000 | $102M | 9.2% |
| IRON | DISC MEDICINE INC | 855,000 | $63M | 5.7% |
| URGN | UROGEN PHARMA LTD | 1,439,996 | $53M | 4.8% |
| APGE | APOGEE THERAPEUTICS INC | 390,000 | $52M | 4.7% |
| MGTX | MEIRAGTX HLDGS PLC | 3,550,000 | $48M | 4.3% |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 500,000 | $37M | 3.4% |
| RZLT | REZOLUTE INC | 6,300,000 | $33M | 3.0% |
| TGTX | TG THERAPEUTICS INC | 535,000 | $29M | 2.7% |
Track Opaleye Management's 13F portfolio: $1.1B in reported holdings, 66 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}